Research Paper Volume 16, Issue 13 pp 10813—10831
An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer
Figure 6. The effect of WDHD1 on immunological status in pan-cancers using the TISIDB. (A) Correlation between WDHD1 and immunomodulators (chemokines, MHC, immune stimulators and receptors). The color indicates the correlation coefficient. (B–E) Correlation of WDHD1 with the expression of chemokines CXCL10 and CXCL5.